Current location:


Choose your location:

  • Platform

    SINOVAC is committed to developing and innovating cutting-edge vaccines to meet the challenge of preventing human diseases worldwide.


  • Pipeline

    SINOVAC upholds a diversified product pipeline and a continuous process of innovation to support its aims to develop safer and more effective vaccines that provide protection from disease for all people, everywhere.


  • Scientific Achievements

    SINOVAC has undertaken nearly 60 national and regional science and technology R&D projects; received two State Scientific and Technology Progress Awards and three national-level institutional technology awards; and published more than 140 SCI papers.


  • Partners

    SINOVAC has built close ties with global top universities and scientific research institutions, and continually dedicates itself to new vaccine R&D.